Innovus Pharma’s Partner Lavasta Receives Approval from Algeria to Market and Sell Zestra® and Zestra Glide® in that Country
InnovAge Holding Corp. (INNV)
NASDAQ:AMEX Investor Relations:
innovuspharma.com
Company Research
Source: Business Wire
The Company Receives Purchase Order from Lavasta for $186,000 SAN DIEGO--(BUSINESS WIRE)-- Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the “Company”) (OTCQB Venture Market: INNV), an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases, announced today that its partner, Lavasta Pharma RFZ-LLC (“Lavasta”), a company based in Dubai, received approval from the Algerian Ministry of Health and Commerce to market and sell the Company’s Zestra® and Zestra Glide® products in that country. In addition, Innovus Pharma announced that it received a purchase order from Lavasta Pharma for these two products for approximately $186,000. Innovus signed an exclu
Show less
Read more
Impact Snapshot
Event Time:
INNV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INNV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INNV alerts
High impacting InnovAge Holding Corp. news events
Weekly update
A roundup of the hottest topics
INNV
News
- InnovAge Holding Corp. (NASDAQ: INNV) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $5.00 price target on the stock.MarketBeat
- InnovAge offers all-inclusive care center that nurtures passions for seniors in Philadelphia [CBS News]CBS News
- InnovAge Celebrates 35 Years of Transforming Senior Care [Yahoo! Finance]Yahoo! Finance
- InnovAge Celebrates 35 Years of Transforming Senior CareGlobeNewswire
- InnovAge Holding Corp (INNV) Q1 2025 Earnings Call Highlights: Revenue Surge and Operational ... [Yahoo! Finance]Yahoo! Finance
INNV
Earnings
- 11/5/24 - In-Line
INNV
Sec Filings
- 12/6/24 - Form 8-K
- 12/3/24 - Form 4
- 11/13/24 - Form SC
- INNV's page on the SEC website